The present findings suggest that DWI visibility provides additional value for distinguishing between nonmalignant and malignant BI-RADS category 4 MRI-detected breast lesions. Particularly for mass lesions, DWI-negative MRI-detected lesions were associated with nonmalignant pathology, indicating a potential role for DWI in reducing unnecessary biopsies.
Usui et al. (Fri,) studied this question.